Glenmark gets USFDA nod for chest pain tablets Ruby Khatun Khatun22 Sept 2017 10:47 AM ISTNew Delhi: Glenmark Pharmaceuticals on Wednesday said its US arm has received final approval from USFDA for its Nitroglycerin sublingual tablets used...
Dr Reddys receives EIR for Srikakulam plant, shares soar Ruby Khatun Khatun22 Sept 2017 10:29 AM ISTNew Delhi: Shares of Dr Reddy's Laboratories Ltd soared by 7.5% after the company said it has received establishment inspection report (EIR) from the...
Strides Shasun gets USFDA nod for lipid lowering drug Ruby Khatun Khatun21 Sept 2017 10:49 AM ISTNew Delhi: Drug firm Strides Shasun on Wednesday said it has received approval from the United States health regulator for generic Omega-3-acid ethyl...
Divis Labs gets 6 USFDA observations for Vizag unit Ruby Khatun Khatun21 Sept 2017 10:27 AM ISTNew Delhi: Drug firm Divis Laboratories on Thursday said it has received six new observations from the US Food and Drug Administration (USFDA) after...
USFDA approves GSK three-in-one drug inhaler for COPD Ruby Khatun Khatun19 Sept 2017 9:57 AM ISTGlaxoSmithKline Plc (GSK) and Innoviva Inc said on Monday the U.S. Food and Drug Administration has approved their triple drug inhaler for the...
Glenmark gets USFDA approval for Rythmol SR generic Ruby Khatun Khatun13 Sept 2017 2:08 PM ISTNew Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for the generic version of Rythmol SR capsules, an...
Strides Shasun gets USFDA nod for kidney stone tablets Ruby Khatun Khatun13 Sept 2017 1:41 PM ISTNew Delhi: Strides Shasun on Tuesday said it has received approval from the US health regulator for potassium citrate extended release tablets used to...
Lupin gets USFDA nod to market anti-infections tablets Ruby Khatun Khatun12 Sept 2017 10:21 AM ISTNew Delhi: Drug firm Lupin has received approval from the US health regulator to market its generic Doxycycline hyclate tablets, used for the...
Zydus Cadila gets USFDA nod to market HIV drug Ruby Khatun Khatun10 Aug 2017 9:30 AM ISTNew Delhi: Drug firm Zydus Cadila on Tuesday said it has received the tentative approval from the US health regulator to market Abacavir and...
FDA rejects Coherus' biosimilar for Amgen's Neulasta Ruby Khatun Khatun13 Jun 2017 9:12 AM ISTn" style="transform: translate3d(0px, 0px, 0px);"Coherus BioSciences Inc said on Monday the U.S. Food and Drug Administration (FDA) denied the...
Zydus Cadila gets USFDA nod to market alcohol abstinence drug Ruby Khatun Khatun29 May 2017 11:56 AM ISTNew Delhi: Drug firm Zydus Cadila has received approval from the US health regulator to market Acamprosate calcium delayed-release tablets used for...
USFDA issues 4 observations for Torrent Pharmaceuticals Indrad plant Ruby Khatun Khatun15 May 2017 12:52 PM ISTNew Delhi: Drug firm Torrent Pharmaceuticals said the US health regulator has issued four observations after inspection of its Indrad facility in...
